Delivery Order SPE2DR25D1017-SPE2DR26F8YUJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (300mL) with a ceiling value of $1,154.53. This competitively awarded, firm fixed-price contract was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,544.96 delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (300 mL) under a firm fixed price contract with an ultimate completion date of August 1, 2025. The award was made competitively with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents one transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (150 mL) with a firm fixed price ceiling value of $1,332.16. This non-set-aside competitive award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of Konvomep 2-84 mg/mL oral suspension in a 300 mL quantity, with a firm fixed price ceiling value of $1,427.88. This non-competitive delivery order, which has an ultimate completion date of September 11, 2025, falls under the Medical Supply Chain division of the Department of Defense. The award represents a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,701.73 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Konvomep 2-84 mg/mL oral suspension in a 300mL volume. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The contract is to be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025....
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a firm fixed price delivery order contract worth $9,294.58 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,615.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the prescription drug KONVOMEP 2-84 MG/ML ORAL SUSP 90ML. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00, which enables the DLA to efficiently procure a wide...
- This is a firm fixed price delivery order for $1,020.00 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a range of pharmaceutical products and medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The order is for the supply of 300 ml oral suspension of the drug KONVOMEP 2-84 mg/ml, with a ceiling value of $6,729.12 and a period of performance through April 9, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a prescription medication, with a ceiling value of $1,641.14 and a period of performance through April 30, 2025. The contract is not set-aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8YUJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Konvomep 2-84 mg/mL oral suspension (150 mL) with a ceiling value of $1,020.18. This is a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively issued with no set-aside designation and represents a child contract under AmerisourceBergen's larger contract vehicle with the DLA. This delivery order falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's primary IDC serves as a global pharmaceutical support vehicle enabling delivery of specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/30/25 |